Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President

Tencent Healthcare's President has observed that smaller biotechnology companies are adopting artificial intelligence technologies more rapidly than their larger counterparts. This trend highlights a shift in how emerging firms leverage computational tools to accelerate drug discovery and development processes. For the healthcare and biotech sector, this agility may provide smaller players with a competitive edge in innovation and efficiency. The observation underscores the growing importance of digital transformation in maintaining a competitive position within the global life sciences market.